Benzylboronic acid

CAS : 4463-42-7

Ref. 3D-FB146781

Informations sur le produit

• Nom: Benzylboronic acid
• Synonymes: boronic acid, B-(phenylmethyl)-, Phenylmethylboronic acid

Description

Benzylboronic acid is a drug target for the treatment of type 2 diabetes. It is used to inhibit glucose monitoring in the body and has been shown to be effective in treating type 2 diabetes by inhibiting gluconeogenesis. Benzylboronic acid has been shown to have an inhibitory effect on toll-like receptor 4 (TLR4) and TLR2, which are involved in the inflammatory response, as well as TLR9, which is involved in the activation of B cells. Benzylboronic acid also inhibits bortezomib, an anti-cancer drug that can cause bone marrow suppression. Benzylboronic acid binds to pyridinium derivatives and esters with nucleophilic groups and forms a covalent bond with them through cross-coupling reactions. This process leads to the formation of a new compound that contains a carbonyl group.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 135.96 g/mol
• Formule: C₇H₉BO₂
• Degré de pureté: Min. 95%
• InChI: InChI=1S/C7H9BO2/c9-8(10)6-7-4-2-1-3-5-7/h1-5,9-10H,6H2
• Code InChI: InChIKey=HBWDWGMBZIFBQE-UHFFFAOYSA-N
• SMILES: OB(O)Cc1ccccc1